Risk of overdiagnosis doesn't deter women from breast cancer screening, study finds

BMJ ◽  
2013 ◽  
Vol 346 (apr23 1) ◽  
pp. f2621-f2621
Author(s):  
Z. Kmietowicz
2015 ◽  
Vol 26 (2) ◽  
pp. 342-350 ◽  
Author(s):  
S. H. Heywang-Köbrunner ◽  
I. Schreer ◽  
A. Hacker ◽  
M. R. Noftz ◽  
A. Katalinic

2011 ◽  
Vol 5 (4) ◽  
pp. 2448-2469
Author(s):  
Adam R. Brentnall ◽  
Stephen W. Duffy ◽  
Martin J. Crowder ◽  
Maureen G. C. Gillan ◽  
Susan M. Astley ◽  
...  

Nanoscale ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 163-174
Author(s):  
Lenitza M. Nieves ◽  
Jessica C. Hsu ◽  
Kristen C. Lau ◽  
Andrew D. A. Maidment ◽  
David P. Cormode

Silver telluride nanoparticles (Ag2Te NPs) show good biocompatibility, enhanced contrast, and blood pool agent characteristics and thus could be used contrast agents for breast cancer screening.


Radiology ◽  
1993 ◽  
Vol 189 (3) ◽  
pp. 661-663 ◽  
Author(s):  
N F Boyd ◽  
R A Jong ◽  
M J Yaffe ◽  
D Tritchler ◽  
G Lockwood ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document